Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2014 Oct 2;22(1):76–86. doi: 10.1038/gt.2014.84

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2015 Macmillan Publishers Limited

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License. The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/

PMC Copyright notice

Both forms of the heterodimeric IL-15 preferentially expand CD8⁺NK cells. (a) Expression of CD8 and Ki-67 within the CD3⁻CD16⁺ total NK cells subset is shown on day 0 and day 9 after the start of the treatment for the individual animals. (b) Blood samples were obtained at the indicated time points and stained with monoclonal antobodies binding to CD3, CD4, CD8 and CD16 and examined by flow cytometry. The data for CD3⁻CD16⁺ (Total NK cells, top panel), for CD3⁻CD16⁺CD8⁺ (CD8⁺NK cells, middle panel) and for CD3⁻CD16⁺CD8⁻ (CD8⁻NK cells, bottom panel) are shown as absolute numbers per μl of blood on the indicated day relative to the absolute number per μl of blood of cells at the day of the start of the treatment. *P<0.05, in comparison to time point 0 (one-way analysis of variance test).